Featured Publications

The following publications were featured on PracticeUpdate,  PracticeUpdate is Elsevier's online physician education portal.  It seeks to connect healthcare professionals with news and information that matters most for patient care.  It is tailored to deliver the latest expert curated content based on the clinician's area of practice. It can be directly accessed here:  www.practiceupdate.com

Dr. Nimeh is an Editorial Contributor at PracticeUpdate.

Written by Tony Nimeh MD

Nocturia: Current Evaluation and Treatment Options

  • An increased focus on nocturia has recently developed due to its association with adverse conditions including heart disease, diabetes, and mortality.
  • Initial assessment should involve frequency volume charts to understand the cause, since there are many possibilities (eg, reduced bladder capacity, sleep disturbances, and elevated urine production).
  • Optimal management of the nocturia depends on accurate diagnosis. Many behavioral and pharmacologic treatment options are available.

Radiation Therapy After Prostatectomy

In a study published in 2009 in The Journal of Urology, the Southwest Oncology Group (SWOG; trial S8794) showed an overall survival benefit and a metastasis-free survival benefit with the use of adjuvant radiation in patients with positive margins of resection after surgery, extracapsular extension, or seminal vesicle invasion within 4 months of prostatectomy in comparison with treatment delayed until evidence of recurrence

By Dr. Tony Nimeh

By Dr. Tony Nimeh

Expert Panel Discussion on Testosterone Therapy

This is a report on an expert panel discussion hosted by the American Urological Association on Testosterone use.  Panelists  argued that testosterone is being underused, not abused. In a 5-year observational study, testosterone replacement therapy was found to decrease body weight, waist circumference, and body mass index.4 Additionally, he cited the benefits of testosterone in metabolic syndrome,4 diabetes,5 osteoporosis,6and benign prostatic hyperplasia/lower urinary tract symptoms.7

He stated that the cardiovascular risk associated with testosterone has not yet been proven, and in comparison to the high prevalence of hypogonadism, he suggested that testosterone therapy is underused.